|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||379.70 - 383.70|
|52 Week Range||300.45 - 388.40|
|Beta (5Y Monthly)||0.66|
|PE Ratio (TTM)||38.19|
|Forward Dividend & Yield||4.80 (1.25%)|
|Ex-Dividend Date||Apr 27, 2022|
|1y Target Est||N/A|
Nearly 60 lawsuits claiming hair relaxer products sold by L'Oreal USA Inc and other companies cause cancer and other health problems will be consolidated in Chicago federal court, according to a Monday order from the Judicial Panel on Multidistrict Litigation. At least 57 lawsuits have been filed in federal courts across the country over the products, which use chemicals to permanently straighten textured hair, court records show. The lawsuits allege the companies knew their products contained dangerous chemicals but marketed and sold them anyway.
French luxury goods group Kering said on Friday it was entering the cosmetics business, with the announcement that it has recruited seasoned Estee Lauder executive Raffaella Cornaggia to head the push into the new segment. "We are building this new area of expertise within our Group to ensure that our brands can fulfill their potential in this category," group Managing Director Jean-Francois Palus said in a statement. Cornaggia has been appointed chief executive officer of Kering Beaute, the statement said.
Does L'Oreal SA (LRLCY) have what it takes to be a top stock pick for momentum investors? Let's find out.